Global Cholesterol Lowering Drugs Market to 2027 - Analysis, Drivers, Restraints & Challenges - ResearchAndMarkets.com

The "Cholesterol Lowering Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Cholesterol Lowering Drugs Market - Scope of the Report

This report on the global cholesterol lowering drugs market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027. The report provides the overall market revenue of the cholesterol lowering drugs market for the period of 2017-2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the cholesterol lowering drugs market for the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the cholesterol lowering drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the cholesterol lowering drugs market.

The report delves into the competitive landscape of the cholesterol lowering drugs market. Key players operating in the cholesterol lowering drugs market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the cholesterol lowering drugs market that have been profiled in this report.

Key Questions Answered

  • What is the sales/revenue generated by each drug class segment of the cholesterol lowering drugs market across all regions during the forecast period?
  • What are the opportunities in the cholesterol lowering drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is likely to expand at the fastest CAGR during the forecast period?
  • Which cholesterol lowering drugs class, indication, and distribution channel segments are expected to generate maximum revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What was the market share or position of different companies operating in the global market in 2018?

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cholesterol Lowering Drugs Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.4. Global Cholesterol Lowering Drugs Market Analysis and Forecasts, 2017-2027

5. Market Outlook

5.1. Pipeline Analysis

5.2. Key Drug Brand Analysis

5.3. Key Merger & Acquisitions

5.4. Pipeline Analysis

5.5. Global Prevalence of Cardiovascular Diseases

6. Global Cholesterol Lowering Drugs Market Analysis and Forecasts, by Drug Class

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Drug Class, 2017-2027

6.3.1. Statins and Combination

6.3.2. PCSK9 Inhibitors

6.3.3. Bile Acid Sequestrants

6.3.4. Fibrates

6.3.5. Cholesterol Absorption Inhibitors

6.3.6. Others

6.4. Market Attractiveness, by Drug Class

7. Global Cholesterol Lowering Drugs Market Analysis and Forecasts, by Indication

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Indication, 2017-2027

7.3.1. Hypercholesterolemia

7.3.2. Coronary Artery Disease

7.3.3. Higher Triglycerides

7.4. Market Attractiveness, by Indication

8. Global Cholesterol Lowering Drugs Market Analysis and Forecasts, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Distribution Channel, 2017-2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Market Attractiveness, by Distribution Channel

9. Global Cholesterol Lowering Drugs Market Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Market Value Forecast, by Region

9.3. Market Attractiveness, by Region

10. North America Cholesterol Lowering Drugs Market Analysis and Forecast

10.1. Introduction

10.2. Market Value Forecast, by Drug Class, 2017-2027

10.3. Market Value Forecast, by Indication, 2017-2027

10.4. Market Value Forecast, by Distribution Channel, 2017-2027

10.5. Market Value Forecast, by Country, 2017-2027

10.6. Market Attractiveness Analysis

11. Europe Cholesterol Lowering Drugs Market Analysis and Forecast

12. Asia Pacific Cholesterol Lowering Drugs Market Analysis and Forecast

13. Latin America Cholesterol Lowering Drugs Market Analysis and Forecast

14. Middle East & Africa Cholesterol Lowering Drugs Market Analysis and Forecast

15. Competition Landscape

15.1. Market Player - Competition Matrix

15.2. Market Share Analysis/Ranking, by Company (2018)

15.3. Company Profiles

15.3.1. Pfizer Inc.

15.3.2. Sanofi

15.3.3. GlaxoSmithKline plc

15.3.4. Novartis AG

15.3.5. Merck & Co., Inc.

15.3.6. Amgen, Inc.

15.3.7. Takeda Pharmaceutical Company Limited

15.3.8. Sun Pharmaceutical Industries Ltd.

15.3.9. AbbVie, Inc.

15.3.10. Mylan N.V.

For more information about this report visit https://www.researchandmarkets.com/r/ju46ft

View source version on businesswire.com: https://www.businesswire.com/news/home/20200402005437/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900